Normal Vesting Date Sample Clauses

Normal Vesting Date. Your Units will be subject to vesting in accordance with the schedule identified in the Grant Notice (the “Normal Vesting Date”) and the number of Units that actually vest may be between 0% and 100% of your Units. If the scheduled Normal Vesting Date is a non-business day, the next following business day will be considered the Normal Vesting Date.
AutoNDA by SimpleDocs
Normal Vesting Date. Your Shares will be subject to vesting in accordance with the schedule identified in the Grant Notice (the “Normal Vesting Date”) and the number of Shares that actually vest may be between 0% and 100% of your Shares. If the scheduled Normal Vesting Date is a non-business day, the next following business day will be considered the Normal Vesting Date.
Normal Vesting Date. Subject to Sections 4.2-4.5, the RSUs granted to the Participant pursuant to this Agreement shall Vest on <<VESTING DATE>> (the “Vesting Date”).
Normal Vesting Date. Subject to Sections 2(b), (c), (d) and (e) and Section 3, the Employee must continue to be employed by the Company or a Subsidiary through the close of the Company’s fiscal year that ends on or about May 30, 2009 for any of the Restricted Stock Units to become non-forfeitable. If the Employee continues to be employed by the Company or a Subsidiary through the close of that fiscal year (the “Normal Vesting Date”), all of the Restricted Stock Units shall thereupon become non-forfeitable.
Normal Vesting Date. Except as otherwise provided in this Award Agreement, the number of Total Units that will vest on the Normal Vesting Date will depend on the achievement of the Performance Objectives, as set forth in the table below, during the Performance Period, as reported to and approved by the Committee. With respect to each Performance Objective, the number of Restricted Stock Units that will vest on the Normal Vesting Date will equal: [a] the applicable Percentage of Total Units, as set forth in the table below, multiplied by [b] the indicated percentage at the Threshold, Target, Stretch Budget and Maximum performance levels; provided, however, that if a Performance Objective is not achieved or is achieved at a performance level which is less than Threshold, all of your Restricted Stock Units with respect to that Performance Objective will be forfeited. If the achievement of a Performance Objective is between performance levels, the number of Restricted Stock Units that vest will be interpolated by the Company. Any Restricted Stock Units that do not vest as of the Normal Vesting Date shall be forfeited. Net Income 40 % 85.71 % 100.00 % 114.00 % 131.37 % Cash Flow (Excluding Capital Expenditures) 30 % 85.65 % 100.00 % 114.20 % 131.34 % Return on Invested Capital 30 % 86.17 % 100.00 % 113.83 % 130.85 % Notwithstanding the foregoing, your Restricted Stock Units may vest earlier in the circumstances described below.
Normal Vesting Date. The PRSUs granted to the Participant pursuant to this Agreement shall Vest upon the attainment of specific performance targets (“Performance Targets”) based upon the performance criteria and for the period (“Performance Period”) set forth on the attached Exhibit A. The performance criteria set forth on Exhibit A shall relate to the financial performance of the Company or a segment or identified business of the Company as selected by the Committee in accordance with Section 9.5 of the Plan. If the Performance Targets are not attained by the end of the Performance Period, then the PRSUs granted pursuant to this Agreement shall be forfeited to the Company without compensation or other consideration. The specific Performance Targets and Performance Period applicable to this PRSU grant shall Form of Restricted Stock Unit Agreement (Performance-Based) – Standard Intl. be as previously determined by the Committee and communicated to the Participant in writing.
Normal Vesting Date. Except as otherwise provided in this Award Agreement, the number of Total Units that will vest on the Normal Vesting Date will depend on the achievement of the following Performance Objectives during the Performance Period: (i) Net Income, (ii) Operating Income and (iii) Days of Working Capital, as set forth in the 2010 Bonus Plan approved by the Committee on October 15, 2009. The Performance Objectives will be dependent upon the Company’s consolidated worldwide performance during the Performance Period. With respect to each Performance Objective, the number of Restricted Stock Units that will vest on the Normal Vesting Date will equal: • Net Income: 33% of the Total Units, multiplied by the indicated percentage at the Threshold, Target, Stretch Budget, Maximum and high performance levels as set forth in the 2010 Bonus Plan approved by the Committee on October 15, 2009; • Operating Income: 33% of the Total Units, multiplied by the indicated percentage at the Threshold, Target, Stretch Budget, Maximum and high performance levels as set forth in the 2010 Bonus Plan approved by the Committee on October 15, 2009; and • Days of Working Capital: 34% of the Total Units, multiplied by the indicated percentage at the Threshold, Target, Stretch Budget, Maximum and high performance levels as set forth in the 2010 Bonus Plan approved by the Committee on October 15, 2009. If a Performance Objective is not achieved or is achieved at a performance level which is less than Threshold, all of your Restricted Stock Units with respect to that Performance Objective will be forfeited. If the achievement of a Performance Objective is between performance levels, the number of Restricted Stock Units that vest will be interpolated by the Company. Any Restricted Stock Units that do not vest as of the Normal Vesting Date shall be forfeited.
AutoNDA by SimpleDocs
Normal Vesting Date. Except as otherwise provided below, your rights in respect of your Matching Shares shall vest on the third anniversary of the date of grant (the "Normal Vesting Date").
Normal Vesting Date. Except as otherwise provided in this Award Agreement, the number of Total Shares that will vest on the Normal Vesting Date will be determined by reference to both: [1] whether the Company’s Total Shareholder Return is positive or negative during the Performance Period; and [2] the relative performance of the Company’s Total Shareholder Return as compared to the Peer Group Companies during the Performance Period. The number of Performance Shares that will vest on the Normal Vesting Date will equal the number of Total Shares, multiplied by the applicable percentage as set forth in the tables below. If the Company’s Total Shareholder Return is between two percentages, the number of Performance Shares that vest will be interpolated by the Company. Notwithstanding the foregoing, any Performance Shares that do not vest as of the Normal Vesting Date shall be forfeited. Relative Performance of Total Shareholder Return to Peer Group Companies Negative Total Shareholder Return Less than 50th Percentile 0 % 50th Percentile 25 % 75th Percentile or Greater 50 % Relative Performance of Total Shareholder Return to Peer Group Companies Positive Total Shareholder Return 25th Percentile or Less 0 % 50th Percentile 50 % 75th Percentile or Greater 100 % As used in this Award Agreement, “Total Shareholder Return” for the Performance Period is calculated by first taking the theoretical value of $100 invested in the Shares at the 30-day average price of the Shares as of the Grant Date (i.e., the average daily closing price over the 30-day period preceding the Grant Date) and the theoretical value of $100 invested with each of the peer group companies in the S&P Special Chemicals Index (the “Peer Group Companies”) using the same 30-day average methodology as of the Grant Date. On the Normal Vesting Date, the value of the Shares (using the average daily closing price over the 30 days preceding the Normal Vesting Date and assuming all dividends are reinvested) is compared with the value of each of the Peer Group Companies (using the same 30-day average methodology as of the Normal Vesting Date and again assuming that all dividends are reinvested). However, your Award may vest earlier in the circumstances described below.

Related to Normal Vesting Date

  • Normal Vesting Subject to the Plan and this Agreement, if the Participant has been in Continuous Employment through the Vesting Date as set forth in Section 1, then the RSUs subject to such Vesting Date will become nonforfeitable (“Vest” or similar terms).

  • Vesting Date All remaining shares of Restricted Stock will become vested on the Vesting Date.

  • Vesting Dates The ISOs shall vest as follows, subject to earlier vesting in the event of a termination of Service as provided in Section 6 or a Change in Control as provided in Section 7:

  • Equity Vesting All of the then-unvested shares subject to each of the Executive’s then-outstanding equity awards will immediately vest and, in the case of options and stock appreciation rights, will become exercisable (for avoidance of doubt, no more than 100% of the shares subject to the then-outstanding portion of an equity award may vest and become exercisable under this provision). In the case of equity awards with performance-based vesting, all performance goals and other vesting criteria will be deemed achieved at the greater of actual performance or 100% of target levels. Unless otherwise required under the next following two sentences or, with respect to awards subject to Section 409A of the Code, under Section 5(b) below, any restricted stock units, performance shares, performance units, and/or similar full value awards that vest under this paragraph will be settled on the 61st day following the CIC Qualified Termination. For the avoidance of doubt, if the Executive’s Qualified Termination occurs prior to a Change in Control, then any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding for 3 months or the occurrence of a Change in Control (whichever is earlier) so that any additional benefits due on a CIC Qualified Termination can be provided if a Change in Control occurs within 3 months following the Qualified Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). In such case, if no Change in Control occurs within 3 months following a Qualified Termination, any unvested portion of the Executive’s equity awards automatically will be forfeited permanently on the 3-month anniversary of the Qualified Termination without having vested.

  • Regular Vesting Except as otherwise provided in the Plan or in this Section 2, your RSUs will vest ratably in three (3) equal annual increments commencing on the first anniversary of the Date of Grant.

  • Time Vesting Subject to Sections 5(b) and 6 below, the RSUs will vest and become nonforfeitable in accordance with and subject to the time vesting schedule set forth on Exhibit A attached hereto, subject to the Participant’s continued status as a Service Provider through each applicable vesting date.

  • Normal Retirement Date The term “Normal Retirement Date” means “Normal Retirement Date” as defined in the primary qualified defined benefit pension plan applicable to the Executive, or any successor plan, as in effect on the date of the Change in Control of the Company.

  • General Vesting The Shares of Restricted Stock shall become vested in the following amounts, at the following times and upon the following conditions, provided that the Termination of Service of the Participant does not occur before the applicable date on which the Shares of Restricted Stock become vested (the “Vesting Date”): Except as otherwise provided in Sections 2(b) and 4 hereof, there shall be no proportionate or partial vesting of Shares of Restricted Stock in or during the months, days or periods prior to each Vesting Date, and all vesting of Shares of Restricted Stock shall occur only on the applicable Vesting Date.

  • Stock Vesting Unless otherwise approved by the Board of Directors, all stock options and other stock equivalents issued after the date of this Agreement to employees, directors, consultants and other service providers shall be subject to vesting as follows: (a) twenty-five percent (25%) of such stock shall vest at the end of the first year following the earlier of the date of issuance or such person’s services commencement date with the Company, and (b) seventy-five percent (75%) of such stock shall vest over the remaining three (3) years.

  • Exercise Period Vesting 4.1. 1 111,111 Series C Warrants to purchase up to 1,111,111 Warrant Shares (50% of Series C Warrants) shall vest on March 1, 2023 (the “Second Vesting Date”) and be exercisable as of the Second Vesting Date and for three (3) years thereafter, subject to Section ‎4.3 below.; provided, however, that the Warrants under this Section ‎4.1 shall expire on the Second Vesting Date in the event the Milestone is not met, and the Partner has notified the Company on its decision to rescind the remaining balance of the Facility; 4.2. 1 111,111 Series C Warrants to purchase up to 1,111,111 Warrant Shares (50% of Series C Warrants) shall vest on September 1, 2023 (the “Third Vesting Date”) and be exercisable as of the Third Vesting Date and for three (3) years thereafter, subject to Section ‎‎4.3 below; provided, however, that the Warrants under this Section ‎4.2 shall expire on the Third Vesting Date in the event the Milestone is not met, and the Partner has notified the Company on its decision to rescind the remaining balance of the Facility; and further provided, that the Warrants under this Section ‎‎4.2 shall expire on the Third Vesting Date pro rata to the amounts of Tranches 3-8 which shall have not been actually withdrawn by the Company. By way of illustration only, (a) if the Company, at its sole discretion, withdraws US$0.5 million out of US$2 million of Tranches 3-8 available under the Agreement, than 833,333 Series C Warrants to purchase up to 833,333 Warrant Shares [75% of Series C Warrants under this Section ‎4.2] shall expire on the Third Vesting Date; and (b) if the Company, at its sole discretion, withdraws US$2 million out of US$2 million of Tranches 3-8 available under the Agreement, than none of Series C Warrants under this Section ‎4.2 shall expire on the Third Vesting Date;

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!